Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

NCT00939965 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: isotretinoin
GENETIC: DNA analysis
GENETIC: polymerase chain reaction
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Children's Cancer and Leukaemia Group